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Introduction: Adipose-derived stem cells (ADSC) are non-hematopoietic mesenchymal stem cells that have shown
great promise in their ability to differentiate into multiple cell lineages. Their ubiquitous nature and the ease of
harvesting have attracted the attention of many researchers, and they pose as an ideal candidate for applications in
regenerative medicine. Several reports have demonstrated that transplanting ADSC can promote repair of injured
tissue and angiogenesis in animal models. Survival of these cells after transplant remains a key limiting factor for
the success of ADSC transplantation. Circulating factors like High Density Lipoprotein (HDL) has been known to
promote survival of other stems cells like bone marrow derived stem cells and endothelial progenitor cells, both by
proliferation and by inhibiting cell apoptosis. The effect of HDL on transplanted adipose-derived stem cells in vivo is
largely unknown.
Methods: This study focused on exploring the effects of plasma HDL on ADSC and delineating the mechanisms
involved in their proliferation after entering the bloodstream. Using the MTT and BrdU assays, we tested the effects
of HDL on ADSC proliferation. We probed the downstream intracellular Akt and ERK1/2 signaling pathways and
expression of cyclin proteins in ADSC using western blot.
Results: Our study found that HDL promotes proliferation of ADSC, by binding to sphingosine-1- phosphate
receptor-1(S1P1) on the cell membrane. This interaction led to activation of intracellular Akt and ERK1/2 signaling
pathways, resulting in increased expression of cyclin D1 and cyclin E, and simultaneous reduction in expression of
cyclin-dependent kinase inhibitors p21 and p27, therefore promoting cell cycle progression and cell proliferation.
Conclusions: These studies raise the possibility that HDL may be a physiologic regulator of stem cells and increasing
HDL concentrations may be valuable strategy to promote ADSC transplantation.Introduction
Adipose-derived stem cells (ADSCs) are multipotent,
and hence can differentiate into a variety of cell types
including adipocytes, chondrocytes, osteocytes, smooth
muscle cells, and endothelial cells [1, 2]. This potential
is the basis of their application in stem cell-based regen-
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unparalleled advantage because they are widely available,
easily harvested and proliferate rapidly in vitro. Autolo-
gous cells are also nonimmunogenic and their use does
not raise ethical concerns, in contrast to embryonic stem
cell use. Although they originate from the mesodermal
lineage, the differentiating potential of ADSCs is not
limited to mesodermal tissues [4]. In recent years, stud-
ies have confirmed that ADSCs transplanted into various
animal models with organ or tissue injury can differenti-
ate into vascular endothelial cells and play an essential
role in injury repair through contributions to angiogen-
esis [5]. Transplantation of ADSCs is a novel therapeutic
option for treatment in various cardiovascular diseases,his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Fig. 1 High density lipoprotein promotes proliferation of adipose-derived stem cells. a Characterization of mice adipose-derived stem cell (ADSC)
markers: cells were labeled with fluorescein isothiocyanate (FITC)-conjugated and phycoerythrin (PE)-conjugated antibodies and evaluated by flow
cytometry. After three passages, ADSCs were positive for CD44 and Sca-1, but negative for CD34 and CD45. Black lines, IgG isotype control. b MTT
assay and d bromodeoxyuridine (BrdU) assay: cell proliferation in mice ADSCs treated with different concentrations (0, 20, 50, 100, 200 μg/ml) of high
density lipoprotein (HDL) for 24 hours. c MTT assay and e BrdU assay: cell proliferation of mice ADSCs treated with HDL over various time periods
(6 to 48 hours). f MTT assay and h BrdU assay: cell proliferation in human ADSCs treated with different concentrations (0, 20, 50, 100, 200 μg/ml) of
HDL for 24 hours. g MTT assay and i BrdU assay: cell proliferation of human ADSCs over various time periods (6 to 48 hours). Bar graphs represent
mean ± standard error of the mean, ***P <0.001. PBS, phosphate-buffered saline
Shen et al. Stem Cell Research & Therapy  (2015) 6:95 Page 3 of 14particularly those involving vascular injury [3, 6]. Low
survival rate of ADSCs after transplantation due to low
proliferation and loss from apoptosis remains a signifi-
cant problem in these cells [7]. The proliferating cap-
acity of these cells is dependent on donor age, type of
adipose tissue, harvesting procedure, culture conditions
and several growth factors [8, 9].
The beneficial role of circulating plasma high density
lipoprotein (HDL) in promoting proliferation of other
stem cell lines, such as vascular endothelial precursor
cells [10] and bone marrow-derived stem cells [11], is
well established. HDL’s primary role is in mediating
reverse cholesterol transport from the lipid-laden mac-
rophages in the vascular wall back to the liver [12].
Clinical evidence supports the inverse association be-
tween cardiovascular disease and HDL cholesterol levels
[13]. In addition to playing an important role in lipid
metabolism, HDL possesses many antioxidative, anti-
inflammatory and antithrombotic effects. The antioxi-
dant effect of HDL is mainly reflected in the inhibition
of low density lipoprotein oxidation, which is a critical
inciting factor in the occurrence and evolution of ath-
erosclerosis. HDL inhibits endothelial cell apoptosis,
promotes endothelial cell repair and activation of endo-
thelial nitric oxide synthase, and performs many other
related anti-inflammatory functions [14].
Transplanted ADSCs are in contact with circulating
HDL, but the effects of HDL on circulating ADSCs are
still not clear. In this study, we propose that HDL pro-
motes ADSC proliferation and regulates the physiology
of ADSCs, thereby providing a therapeutic target to pro-
mote repair of vascular injury.
Materials and methods
Isolation, culture and identification of adipose-derived
stem cells
All animal experimental procedures were approved by
the Ethics Committee of Animal Research, Peking Uni-
versity Health Science Center, and the investigation con-
formed to the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of
Health (National Institutes of Health publication up-
dated in 2011). Samples of adipose tissue were collected
from the groins of 6-week-old ICR mice. The adiposetissue was then shredded into small pieces and digested with
10 mg/ml collagenase I (Sigma-Aldrich, St. Louis, MO, USA)
for 1 hour at 37 °C. The digestion was terminated by adding
Dulbecco’s modified Eagle’s medium (DMEM) medium
(Hyclone, USA) containing 10 % fetal bovine serum (FBS;
Hyclone, Logan, UT, USA) and 1 % penicillin/streptomycin
(GIBCO, Gibco, part of Life Technologies, Carlsbad, CA,
USA). The tissue suspension was centrifuged at 200 × g for 5
minutes and the pellet was suspended in fresh medium, and
then plated into 100 mm dishes. Nonadherent cells were re-
moved by replacing fresh medium after 24 hours. The cells
were passaged following trypsin digestion when they reached
90 % confluence. After three passages, cells were harvested
with 0.05 % trypsin digestion, washed three times with
phosphate-buffered saline (PBS) and incubated with anti-
bodies CD34-fluorescein isothiocyanate, CD45-fluorescein
isothiocyanate, CD44-phycoerythrin (PE) and Sca1-PE (BD
Biosciences, San Jose, CA, USA) at 37 °C for 30 minutes.
The cells were then washed three times with PBS and sus-
pended in 300 μl PBS, analyzed with flow cytometry and at
least 104 events per sample were recorded. CD29, CD90 and
CD105 were also tested using APC anti-mouse CD29 (Milte-
nyi Biotec, Bergisch Gladbach, Germany), APC Arm hamster
IgG Isotype Ctrl (eBioscience, San Diego, CA, USA), PE anti-
rat CD90/mouse CD90.1 (Biolegend, San Diego, CA, USA),
PE mouse IgG1,κ Isotype Ctrl (Biolegend, San Diego, CA,
USA), PE anti-mouse CD105 (Biolegend, San Diego, CA,
USA), and PE rat IgG2a,κ Isotype Ctrl (Biolegend, San Diego,
CA, USA).
The human ADSCs were purchased from American
Type Culture Collection (PCS-500-011; ATCC, USA).
The cells were cultured in Mesenchymal Stem Cell Basal
Medium (PCS-500-030; ATCC) with a Mesenchymal
Stem Cell Growth Kit (PCS-500-040; ATCC) and 1 %
penicillin/streptomycin (GIBCO), and were passaged
after trypsinization when they reached 90 % confluence.
Preparation of high density lipoprotein
HDL was prepared as described in our previous report
[13]. Plasma samples were collected from healthy volun-
teers. The study protocol was approved by the Institu-
tional Review Board of Peking University Health Science
Center. Each participant gave written, informed consent
after the nature of the procedure was explained. The
Fig. 2 (See legend on next page.)
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Fig. 2 Akt and ERK1/2 signal pathways, cell cyclins (cyclin D1/E) and cyclin-dependent kinase inhibitors (p21/p27) are involved in high density lipoprotein promoting
mice adipose-derived stem cell proliferation. Western blot expression of various signal pathway molecules and cell cycle regulatory proteins of mice adipose-derived
stem cells which were treated with high density lipoprotein (HDL) at different concentrations a and at various time points h. b p-Akt, c p-ERK, d cyclin D1, e cyclin E,
f p21, g p27, i p-Akt, j p-ERK, k cyclin D1, l cyclin E,m p21, n p27. Results are the mean ± standard error of the mean of three experiments for each
condition determined by densitometry relative to corresponding total protein/beta-actin. *P <0.05, **P <0.01, ***P <0.001
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saline (1.006 g/ml) was layered over the adjusted plasma
to form a discontinuous NaCl/KBr density gradient. The
samples with gradient were centrifuged at 350,000 × g for
3.5 hours at 4 °C. The purity of HDL was evaluated by 12 %
SDS-PAGE and western blot analysis using goat anti-apoA-I
polyclonal antibody (DiaSorin, Stillwater, OK, USA) and was
quantified through the measurement of apolipoprotein A-I
content by nephelometry (Dimension XPand; Dade Behring,
Marburg, Germany). HDL was dialyzed with PBS, sterilized
and stored in the dark at 4 °C for use within 1 month.Treatment with HDL, cell signaling pathway inhibitor and
sphingosine-1-phosphate type 1 receptor inhibitor
The ADSCs were passaged after trypsin digestion when
they reached 90 % confluence in 100 mm dishes, and
then plated into six-well plates. When they reached a
confluence of 70 %, for mice ADSCs the medium was
changed with fresh DMEM containing 1 % FBS, but for
human ADSCs the medium was replaced with Mesen-
chymal Stem Cell Basal Medium (PCS-500-030; ATCC)
containing 1 % FBS, and then exposed to HDL at different
concentrations (0, 20, 50, 100, 200 μg/ml). To study
the effects of the HDL temporally, the cells were exposed
to 100 μg/ml HDL at different time points (0, 0.5, 1, 2, 4
hours). Before HDL treatment the cells were incubated
with either Akt inhibitor (LY294002, 25 μM) or mitogen-
activated protein kinase inhibitor (PD98059, 50 μM) for 2
hours or with sphingosine-1-phosphate type 1 (S1P1) re-
ceptor inhibitor (VPC23019, 15 μM) for 30 minutes in
medium without FBS. After pretreatment, the cells were
cultured with 100 μg/ml HDL for 1 hour in fresh DMEM
containing 1 % FBS or Mesenchymal Stem Cell Basal
Medium containing 1 % FBS respectively.MTT assay and bromodeoxyuridine assay
For the MTT assay, cells (3,000 cells/well) were plated
into a 96-well plate and cultured overnight, and then the
medium was replaced with fresh DMEM containing 1 %
FBS or Mesenchymal Stem Cell Basal Medium contain-
ing 1 % FBS respectively. The cells were incubated in dif-
ferent concentrations of HDL (0, 20, 50, 100, 200 μg/ml)
for 24 hours and treated with 100 μg/ml HDL at different
time points (6, 12, 24, 48 hours), and then 10 μl MTT re-
agent was added to each well for an additional 4 hours.
Dimethylsulfoxide (200 μl) was added to each well andthen absorbance at 570 nm was measured using an
enzyme-linked immunosorbent assay reader.
For bromodeoxyuridine (BrdU) assay (Roche, Mannheim,
Germany), the cells are prepared similarly to those for the
MTT assay. After incubation with HDL, 10 μl BrdU was
added to the medium and incubated for an additional 4 hours.
The cells were then fixed, and incubated with BrdU antibody
for 60 minutes. After three washes, cells were incubated with
200 μl substrate solution for 5 to 30 minutes and 25 μl of 1
M H2SO4 was added. Finally, absorbance at 450 nm was mea-
sured using an enzyme-linked immunosorbent assay reader.
Western blot analysis
ADSCs were washed three times with PBS, and lysed in
RIPA lysis buffer on ice for 30 minutes. The lysates were
centrifuged at 4 °C, 12,000 X g for 10 minutes. The super-
natant was collected. Equal amounts of protein (40 μg) were
separated by 12 % SDS-PAGE and transferred to nitrocellu-
lose membranes. The membranes were blocked with 5 %
nonfat milk in Tris-buffered saline/Tween 20 for 1 hour
and incubated with primary antibody at 4 °C overnight, and
then incubated with appropriate horseradish peroxidase-
conjugated secondary antibody. The immune complexes
were detected by electrochemiluminescence.
Statistical analysis
Statistical analysis was performed with Graph Pad prism 5
software (version 5.01; GraphPad Software, La Jolla, CA,
USA). All data are reported as mean ± standard error of
the mean. The significant differences between means were
evaluated using the unpaired t test. P <0.05 was considered
a statistically significant difference.
Results
Characterization of mice adipose-derived stem cells
The adherent cultured mice ADSCs display a fibroblast-
like morphology and expand in a monolayer on tissue
culture plates when observed under a light microscope.
Flow cytometry was performed to confirm the pheno-
type of the adherent cells. The results showed that these
cells are positive for CD44 (91.44 %) and Sca-1 (80.13 %)
and negative for CD34 (0.68 %) and CD45 (1.50 %)
(Fig. 1a). These results are consistent with previously
published reports [4, 7] and confirm that the cells were
mice ADSCs. CD29, CD90 and CD105 were also tested
(Additional file 1), which also confirm that the cells were
mice ADSCs.
Fig. 3 (See legend on next page.)
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Fig. 3 Akt and ERK1/2 signal pathways, cell cyclins (cyclin D1/E) and cyclin-dependent kinase inhibitors (p21/p27) are involved in high density
lipoprotein promoting human adipose-derived stem cell proliferation. Western blot expression of various signal pathway molecules and cell cycle
regulatory proteins of human adipose-derived stem cells which were treated with high density lipoprotein (HDL) at different concentrations a
and at various time points h. b p-Akt, c p-ERK, d cyclin D1, e cyclin E, f p21, g p27, i p-Akt, j p-ERK, k cyclin D1, l cyclin E, m p21, n (p27). Results
are the mean ± standard error of three experiments for each condition determined by densitometry relative to corresponding total protein/beta-actin.
*P <0.05, **P <0.01, ***P <0.001
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cell proliferation
The proliferative effects of different HDL concentrations
on ADSCs incubated with HDL for 24 hours were mea-
sured with MTT assay and BrdU incorporation assay.
Our results indicate that there is a dose-dependent
HDL-stimulated proliferation of ADSCs with the highest
proliferation at a concentration of 100 or 200 μg/ml
(Fig. 1b,d,f,h). Time-dependent effects of HDL in pro-
moting proliferation of ADSCs were also tested. We
found that the effect of HDL promoting ADSC prolifera-
tion reaches a maximum at 24 hours (Fig. 1c,e,g,i).
Western blot results showed that phosphorylation of
Akt and extracellular signal-related kinase (ERK)1/2 and
expression of cyclin D1 and cyclin E were significantly
increased, while the expression of cyclin-dependent kin-
ase inhibitors (CKIs) p21 and p27 were reduced mark-
edly (Figs. 2a,h and 3a,h).
Akt and ERK1/2 signaling pathways play an essential role in
HDL-induced proliferation of adipose-derived stem cells
Pretreating ADSCs with Akt signaling pathway inhibitor
LY294002 and ERK1/2 signaling pathway inhibitor
PD98059 for 2 hours before incubation with HDL sup-
pressed the HDL-stimulated ADSC proliferation (Figs. 4a,b
and 5a,b). The results of western blot analysis also show
that pretreatment with the two signaling pathway inhibi-
tors blocked the effect of Akt and ERK1/2 activation,
attenuated the HDL-induced increment of cell cyclins
(cyclin D1/E) and increased the expression of CKIs (p21/
p27). These results suggest that HDL required functional
activation of Akt and ERK1/2 signal pathways to mediate
its proliferative effect on ADSC (Figs. 4c and 5c).
Involvement of S1P1 receptor in HDL-induced proliferation
of adipose-derived stem cells
We tested the expression of several classic HDL recep-
tors on ADSCs. To our surprise, SR-BI [15], ABCA-1
[16] and ABCG-1 [16] were not expressed, while S1P1
receptor [17] from the family of S1P receptors was
expressed (Figs. 6a and 7a). After pretreatment with
S1P1 receptor inhibitor VPC23019, HDL-stimulated
ADSC proliferation decreased significantly (Figs. 6b,c
and 7b,c). The results of western blot analysis suggested
that Akt and ERK1/2 signaling pathways are not acti-
vated, and the expressions of cell cyclin and CKI werenot changed significantly compared with control. These
results suggested that S1P1 receptors participate in
HDL-induced proliferation of ADSCs and play an essential
role proximal to Akt and ERK1/2 signals (Figs. 6d and 7d).
Discussion
The exploration of stem cell transplantation-based ther-
apies for various diseases including cardiovascular dis-
eases is being carried out widely in the field of
regenerative medicine. The major pitfall to all these ther-
apies is the low survival and weak proliferation of the
stem cells after transplantation, which unfortunately is
the major determinant of therapeutic efficacy [7]. Al-
though many attempts have been made to improve this
pitfall, the complexity of the factors involved makes
them difficult to overcome [18]. Since these transplanted
cells enter the bloodstream first and then the micro-
environment of tissues, altering specific circulating or
local tissue factors could significantly improve the sur-
vival and proliferation rate of transplanted stem cells.
Modification of these circulating or local factors could
be a valuable step to improve the success rates of these
therapies.
HDL not only plays an important role in cholesterol
metabolism and cardiovascular disease [18], but also has
antioxidant, anti-apoptotic and anti-aging effects on ves-
sels in vivo [17]. There are many reports that confirm
HDL can reduce the risk of the cardiovascular diseases.
The effects of HDL on protecting vascular endothelial
cells [19], and for promoting proliferation of vascular
endothelial precursor cells [11] and bone marrow-
derived stem cells [12], have been widely reported.
Published literature suggests that phosphatidylinositol
3-kinase/Akt-dependent cyclin D1 activation plays an
essential role in HDL-induced endothelial precursor
cell proliferation [11], and that HDL promotes the
proliferation of bone marrow-derived stem cells via activa-
tion of phosphatidylinositol 3-kinase/Akt and mitogen-
activated protein kinase/ERK1/2 pathways. This well-
established action of HDL raises the possibility of its
potential effect on other exogenous stem cells which enter
the body.
In previous reports, the proliferation of ADSCs was
shown to be promoted by single growth factors such as
epidermal growth factor, insulin-like growth factor-1 and
fibroblast growth factor-2 [20] and also enhanced by a
Fig. 4 High density lipoprotein-mediated proliferation of mice adipose-derived stem cells is significantly decreased when treated with signal pathway
inhibitors (LY294002 or/and PD98059). a MTT assay and b bromodeoxyuridine (BrdU) assay: mice adipose-derived stem cells (ADSCs) were pretreated
LY249002 or/and PD98059 for 2 hours prior to 24-hour incubation with high density lipoprotein (HDL). Data show that the proliferation of mice ADSCs
was obviously inhibited with LY249002 and PD98059 treatment. c Western blot change in expression of various signal pathway molecules and cell cycle
regulatory proteins in mice ADSCs that were pretreated with LY249002 or/and PD98059 for 2 hours prior to 1-hour incubation with HDL. d p-Akt,
e p-ERK, f cyclin D1, g cyclin E, h p21, i p27. Results are the mean ± standard error of three experiments for each condition determined by
densitometry relative to corresponding total protein/beta-actin. *P <0.05, **P <0.01, ***P <0.001
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Fig. 5 High density lipoprotein-mediated proliferation of human adipose-derived stem cells is significantly decreased when treated with signal
pathway inhibitors (LY294002 or/and PD98059). a MTT and b bromodeoxyuridine (BrdU) assay: human mice adipose-derived stem cells (ADSCs)
were pretreated with LY249002 or/and PD98059 for 2 hours prior to 24-hour incubation with high density lipoprotein (HDL). Data show that the
proliferation of human ADSCs was obviously inhibited with LY249002 and PD98059 treatment. c Western blot change in expression of various
signal pathway molecules and cell cycle regulatory proteins in human ADSCs that were pretreated with LY249002 or/and PD98059 for 2 hours
prior to 1-hour incubation with HDL. d p-Akt, e p-ERK, f cyclin D1, g cyclin E, h p21, i p27. Results are the mean ± standard error of three
experiments for each condition determined by densitometry relative to corresponding total protein/beta-actin. *P <0.05, **P <0.01, ***P <0.001
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Fig. 6 S1P1 receptor contributes to high density lipoprotein-induced cell proliferation of mice adipose-derived stem cells. a Western blot confirms the
presence of several classical receptors for high density lipoprotein (HDL) in mice adipose-derived stem cells (ADSCs). Human umbilical vein
endothelial cells (EC) were used as a positive control to validate the result. Data show that only S1P1, a classical receptor for HDL, was expressed in
mice ADSCs. b MTT assay and c bromodeoxyuridine (BrdU) assay show that the effect of HDL-promoting cell proliferation in mice ADSCs was blocked
when pretreated with S1P1 receptor specific inhibitor VPC23019 for 30 minutes prior to 24 hours of HDL treatment. d Western blot change in
expression of various signal pathway molecules and cell cycle regulatory proteins in mice ADSCs pretreated with S1P1 receptor inhibitor VPC23019 for
30 minutes prior to incubation with HDL for 1 hour. e p-Akt, f p-ERK, g cyclin D1, h cyclin E, i p21, j p27. Results are the mean ± standard error
of three experiments for each condition determined by densitometry relative to corresponding total protein/beta-actin. *P <0.05, **P <0.01,
***P <0.001
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Fig. 7 S1P1 receptor contributes to high density lipoprotein-induced cell proliferation of human adipose-derived stem cells. a Western blot confirms
the presence of several classical receptors for high density lipoprotein (HDL) in human adipose-derived stem cells (ADSCs). Human umbilical vein
endothelial cells (EC) were used as a positive control to validate the result. Data show that only S1P1, a classical receptor for HDL, was expressed in
human ADSCs. b MTT assay and c bromodeoxyuridine (BrdU) assay show that the effect of HDL-promoting cell proliferation in human ADSCs was
blocked when pretreated with S1P1 receptor specific inhibitor VPC23019 for 30 minutes prior to 24 hours of HDL treatment. d Western blot change in
expression of various signal pathway molecules and cell cycle regulatory proteins in human ADSCs pretreated with S1P1 receptor inhibitor VPC23019
for 30 minutes prior to incubation with HDL for 1 hour. e p-Akt, f p-ERK, g cyclin D1, h cyclin E, I p21, j p27. Results are the mean ± standard error of
three experiments for each condition determined from densitometry relative to corresponding total protein/beta-actin. *P <0.05, **P <0.01, ***P <0.001
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growth factor-2 is a strong growth-stimulating factor
and is essential for the long-term proliferation and self-
renewal of ADSCs through the ERK1/2 signal pathway
[21]. The proliferation of ADSCs can also be advanced
by platelet-derived growth factor via Jun amino-terminal
kinase activation [22], by sphingosylphosphorylcholine
through activation of c-jun N-terminal kinase [23], and
via oncostatin M by activation of the microtubule-
associated protein kinase/ERK and the JAK/STAT1 path-
ways [24].
Our study found that isolated HDL from plasma has a
significant role in promoting proliferation of ADSCs.
HDL stimulates Akt and ERK1/2 phosphorylation and
activates Akt and ERK1/2 signaling pathways in ADSCs.
These two signal pathways involved in cell survival and
cell proliferation have been widely reported in a large
number of previous studies. Cell proliferation is tightly
controlled by factors regulating cell cycle progression.
The cell cycle progression is mainly regulated by three
types of proteins: cell cyclins, cyclin-dependent kinases
(CDKs) and CKIs, which have a role in negative regula-
tion of cell cycle progression [25]. There are a number
of cell cycle regulation sites, and the most classic site is
G1/S phase transition regulation. Cyclin D binding to
CDK4/6, and cyclin E binding to CDK2 jointly promoteFig. 8 Hypothesized model for the molecular mechanism involved in high
cells. High density lipoprotein (HDL) binds to S1P1 receptor in the plasma
phosphorylation, activates Akt and ERK1/2 signaling pathways in cytoplasm
reduces the expression of cyclin-dependent kinase inhibitors (p21 and p27the G1/S phase progression. CKIs p21/p27 can bind to
CDK2/4/6, exerting the function of blocking the effect
of cyclin–CDK complexes, and thus preventing G1/S
phase transition [25, 26]. Together, these classic types of
proteins play essential roles in regulating cell cycle
progression [26]. In this study, we find that HDL treat-
ment increases cyclin D1/E expression of ADSCs, and
reduces expression of p21/p27, thus promoting cell
cycle progression.
To further illustrate the specific pathways through
which HDL promotes proliferation of ADSCs, we exam-
ined the expression of several classic HDL receptors on
ADSCs. Surprisingly, not only SR-BI [14] and ABCA-1
[27] but also S1P2 (data not shown) and S1P3 receptors
were not expressed, while only S1P1 [15] was expressed.
Inhibitors of S1P1 receptors diminished the effect of
HDL on promoting ADSC proliferation, suggesting that
S1P1 is the important receptor for HDL’s action in ADSCs.
Sphingosine-1-phosphate receptors are G-protein-coupling
receptors which include five members: S1P1, S1P2, S1P3,
S1P4 and S1P5 receptors [28, 29]. S1P1 and S1P3 are the
most widely expressed, whereas S1P2 is expressed in the
brain, especially in white matter tract regions, and S1P4
and S1P5 expression is confined to blood vascular cells
and the central nervous system, respectively. S1P1, S1P3
and S1P5 bind sphingosine-1-phosphate with high affinity,density lipoprotein promoting proliferation of adipose-derived stem
membrane of adipose-derived stem cells, stimulates Akt and ERK1/2
, increases expression of cell cyclins (cyclin D1 and cyclin E), and
) to promote cell cycle progression and to achieve cell proliferation
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and S1P4. The activation of S1P receptors can lead to acti-
vation of the small guanosine triphosphatase (GTPase)
Ras and the ERK, resulting in cell proliferation [29]. S1P
receptor signaling is also associated with the activation of
phosphatidylinositol 3-kinase and Akt involved in cell sur-
vival and inhibiting apoptosis [30]. Activation of protein
kinase C and phospholipase C are also attributed to S1P
receptors, which can cause increasing free calcium in
cytoplasm [31].
The major limitation of this study is that only one cell
signaling pathway was explored based on prior literature,
but other pathways could also be involved. S1P1 recep-
tors have diverse effects on various signaling pathways
and these pathways may be relevant in the ADSCs,
which need to be explored systematically using high-
throughput protein microarray technologies. Future
studies will focus on confirming these exciting findings
in an in vivo animal model using effective live cell
markers tracked with sensitive in vivo signal monitoring
equipment. This would need to be followed up with
well-designed clinical trials exploring the effect of increas-
ing HDL levels on the success of ADSC transplantation.
Conclusions
In summary, this study is the first to explore the effects
of HDL on ADSCs. Our results confirm that HDL can
promote proliferation of ADSCs. HDL acts through the
S1P1 receptor and activates Akt and ERK1/2 signaling
pathways, thereby upregulating cyclin D1/E expression,
and decreasing expression of CKIs p21 and p27, thus
promoting cell cycle progression and proliferation (Fig. 8).
This study raises the therapeutic option of raising levels of
HDL to assist in improving post-transplant survival rate
of ADSC, which needs to be further explored in future
studies.
Additional file
Additional file 1: is a figure showing flow cytometry data for CD29,
CD90 and CD105 of mice ADSCs.
Abbreviations
ADSC: adipose-derived stem cell; BrdU: bromodeoxyuridine; CDK: cyclin-
dependent kinase; CKI: cyclin-dependent kinase inhibitor; DMEM: Dulbecco’s
modified Eagle’s medium; ERK: extracellular signal-related kinase; FBS: fetal
bovine serum; HDL: high density lipoprotein; PBS: phosphate-buffered saline;
PE: phycoerythrin; S1P1: sphingosine-1-phosphate type 1.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HS, EZ, XiW, ZF, CN and YL performed most of the experiments and
produced most of the figures. BP, AVM, XuW and SP analyzed the data. LZ
and YW supervised the project, designed the experiments and wrote the
manuscript. All authors read and approved the final manuscript.Acknowledgements
This work was supported by grant 2011CB503900 from the ‘973’ National
S&T Major Project, grants 81270321, 81170101 and 81370235 from the
National Natural Science Foundation of China, and grant 7122106 from the
Natural Science Foundation of Beijing, China.
Author details
1Department of Pathology, Shantou University Medical College, Shantou,
Guangdong 515041, China. 2Department of Neurosurgery, The First Affiliated
Hospital of Soochow University, Suzhou 215006, China. 3The Institute of
Cardiovascular Sciences and Institute of Systems Biomedicine, School of Basic
Medical Sciences, Key Laboratory of Molecular Cardiovascular Sciences of
Education Ministry, Peking University Health Science Center, Beijing 100191,
China. 4Hutchison Medi Pharma (Suzhou), Jiangsu 215125, China.
5Department of Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
6Institute of Hypoxia Medicine, Wenzhou Medical University, Zhejiang
325035, China.
Received: 7 September 2014 Revised: 26 March 2015
Accepted: 7 May 2015
References
1. Taha MF, Hedayati V. Isolation, identification and multipotential
differentiation of mouse adipose tissue-derived stem cells. Tissue Cell.
2010;42:211–6.
2. Witkowska-Zimny M, Walenko K. Stem cells from adipose tissue. Cell Mol
Biol Lett. 2011;16:236–57.
3. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, et al.
IFATS collection: in vivo therapeutic potential of human adipose tissue
mesenchymal stem cells after transplantation into mice with liver injury.
Stem Cells. 2008;26:2705–12.
4. Schaffler A, Buchler C. Concise review: adipose tissue-derived stromal
cells – basic and clinical implications for novel cell-based therapies. Stem
Cells. 2007;25:818–27.
5. Cao Y, Sun Z, Liao L, Meng Y, Han Q, Zhao RC. Human adipose
tissue-derived stem cells differentiate into endothelial cells in vitro and
improve postnatal neovascularization in vivo. Biochem Biophys Res
Commun. 2005;332:370–9.
6. Fan W, Cheng K, Qin X, Narsinh KH, Wang S, Hu S, et al. mTORC1 and
mTORC2 play different roles in the functional survival of transplanted
adipose-derived stromal cells in hind limb ischemic mice via regulating
inflammation in vivo. Stem Cells. 2013;31:203–14.
7. Cutri BA, Hime NJ, Nicholls SJ. High-density lipoproteins: an emerging target
in the prevention of cardiovascular disease. Cell Res. 2006;16:799–808.
8. Negre-Salvayre A, Dousset N, Ferretti G, Bacchetti T, Curatola G, Salvayre R.
Antioxidant and cytoprotective properties of high-density lipoproteins in
vascular cells. Free Radic Biol Med. 2006;41:1031–40.
9. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD,
et al. High-density lipoprotein cholesterol and cardiovascular disease. Four
prospective American studies. Circulation. 1989;79:8–15.
10. Yong Lee W, Joo Park K, Beom Cho Y, Nam Yoon S, Ho Song K, Kim DS,
et al. Autologous adipose tissue-derived stem cells treatment demonstrated
favorable and sustainable therapeutic effect for crohn’s fistula. Stem cells.
2013;31:2575–81.
11. Zhang Q, Yin H, Liu P, Zhang H, She M. Essential role of HDL on endothelial
progenitor cell proliferation with PI3K/Akt/cyclin D1 as the signal pathway.
Exp Biol Med. 2010;235:1082–92.
12. Xu J, Qian J, Xie X, Lin L, Ma J, Huang Z, et al. High density lipoprotein
cholesterol promotes the proliferation of bone-derived mesenchymal stem
cells via binding scavenger receptor-B type I and activation of PI3K/Akt,
MAPK/ERK1/2 pathways. Mol Cell Biochem. 2012;371:55–64.
13. Liu D, Ji L, Zhang D, Tong X, Pan B, Liu P, et al. Nonenzymatic glycation of
high-density lipoprotein impairs its anti-inflammatory effects in innate
immunity. Diabetes Metab Res Rev. 2012;28:186–95.
14. Nofer JR, van Eck M. HDL scavenger receptor class B type I and platelet
function. Curr Opin Lipidol. 2011;22:277–82.
15. Wilkerson BA, Grass GD, Wing SB, Argraves WS, Argraves KM. Sphingosine
1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high
density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as
compared with albumin-S1P via effects on levels, trafficking, and signaling
of S1P1. J Biol Chem. 2012;287:44645–53.
Shen et al. Stem Cell Research & Therapy  (2015) 6:95 Page 14 of 1416. Suzuki G, Iyer V, Lee TC, Canty Jr JM. Autologous mesenchymal stem cells
mobilize cKit+ and CD133+ bone marrow progenitor cells and improve
regional function in hibernating myocardium. Circ Res. 2011;109:1044–54.
17. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM.
Antiinflammatory properties of HDL. Circ Res. 2004;95:764–72.
18. Sala F, Catapano AL, Norata GD. High density lipoproteins and
atherosclerosis: emerging aspects. J Geriatr Cardiol. 2012;9:401–7.
19. Tran-Dinh A, Diallo D, Delbosc S, Varela-Perez LM, Dang QB, Lapergue B,
et al. HDL and endothelial protection. Br J Pharmacol. 2013;169:493–511.
20. Hebert TL, Wu X, Yu G, Goh BC, Halvorsen YD, Wang Z, et al. Culture effects
of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF)
on cryopreserved human adipose-derived stromal/stem cell proliferation
and adipogenesis. J Tissue Eng Regen Med. 2009;3:553–61.
21. Zaragosi LE, Ailhaud G, Dani C. Autocrine fibroblast growth factor 2
signaling is critical for self-renewal of human multipotent adipose-derived
stem cells. Stem Cells. 2006;24:2412–9.
22. Kang YJ, Jeon ES, Song HY, Woo JS, Jung JS, Kim YK, et al. Role of c-Jun
N-terminal kinase in the PDGF-induced proliferation and migration of
human adipose tissue-derived mesenchymal stem cells. J Cell Biochem.
2005;95:1135–45.
23. Jeon ES, Song HY, Kim MR, Moon HJ, Bae YC, Jung JS, et al.
Sphingosylphosphorylcholine induces proliferation of human adipose
tissue-derived mesenchymal stem cells via activation of JNK. J Lipid Res.
2006;47:653–64.
24. Song HY, Jeon ES, Jung JS, Kim JH. Oncostatin M induces proliferation of
human adipose tissue-derived mesenchymal stem cells. Int J Biochem Cell
Biol. 2005;37:2357–65.
25. Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression: new therapeutic
target for vascular proliferative disease. Circulation. 1998;98:82–9.
26. Cobrinik D. Pocket proteins and cell cycle control. Oncogene. 2005;24:2796–809.
27. Yvan-Charvet L, Wang N, Tall AR. Role of HDL, ABCA1, and ABCG1
transporters in cholesterol efflux and immune responses. Arterioscler
Thromb Vasc Biol. 2009;30:139–43.
28. Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from
sphingolipids. Nat Rev Mol Cell Biol. 2008;9:139–50.
29. He X, H’Ng SC, Leong DT, Hutmacher DW, Melendez AJ.
Sphingosine-1-phosphate mediates proliferation maintaining the
multipotency of human adult bone marrow and adipose tissue-derived
stem cells. J Mol Cell Biol. 2010;2:199–208.
30. Nakahara T, Iwase A, Nakamura T, Kondo M, Bayasula, Kobayashi H, et al.
Sphingosine-1-phosphate inhibits H2O2-induced granulosa cell apoptosis
via the PI3K/Akt signaling pathway. Fertility and sterility. 2012;98:1001-8 e1.
31. Maceyka M, Harikumar KB, Milstien S, Spiegel S. Sphingosine-1-phosphate
signaling and its role in disease. Trends Cell Biol. 2012;22:50–60.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
